Financial TimesRoche to buy Carmot for up to $3.1bn as race for obesity drugs intensifiesDec 4Donato Paolo ManciniBy Donato Paolo Mancinimore_vert
GlobeNewswireRoche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets ...Dec 4more_vert
BloombergRoche to Buy Obesity Drug Maker Carmot for $3.1 BillionDec 4Paula DoeneckeBy Paula Doeneckemore_vert
CNBCRoche enters obesity market with Carmot takeover but drugs may not be available until 2030Dec 4Karen GilchristBy Karen Gilchristmore_vert